跳至主要内容
临床试验/ACTRN12624001196538
ACTRN12624001196538尚未招募Unknown

The effectiveness of self-guided versus clinician-guided digital cognitive behavioural therapy for insomnia, versus digital sleep health education, on insomnia symptom severity in primary care priority populations: A three-arm randomised controlled effectiveness-implementation trial.

Department of Health and Aged Care - Medical Research Future Fund (MRFF)0 个研究点目标入组 405 人开始时间: 2024年9月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
405
主要终点
Insomnia Severity Index (ISI) questionnaire.<br><br>[Between-group change in self-reported insomnia severity on the Insomnia Severity Index (ISI) questionnaire. Between-group change in ISI scores from baseline to 10-weeks and 6-month follow-up post-randomisation.]

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 No limit(—)
性别
All

入选标准

  • General practitioner inclusion criteria;
  • Currently practicing as a general practitioner in Australia.Patient inclusion criteria;
  • Aged at least 18 years
  • Referred by a participating general practitioner, according to GP-identified insomnia symptoms, general practice electronic medical record notes identifying diagnosis or clinical problem of insomnia lasting at least 3 months, and/or prescription of sedatives or hypnotics for insomnia symptoms
  • Reliable access to a computer, tablet, or smartphone with internet access.
  • Basic English language comprehension as required for CBTi program participation.
  • Active patients of the participating general practice clinic (have attended at least 3 times in the last two years).
  • Insomnia symptoms according to an Insomnia Severity Index score of at least 15, that have persisted for at least 3 months (indicative of chronic insomnia)

排除标准

  • Doctor-diagnosed sleep disorders other than insomnia (e.g. sleep apnoea, narcolepsy).
  • Excessive daytime sleepiness (Epworth Sleepiness Scale Score >15).
  • Current psychological treatment for insomnia,
  • Shift work within the past 3 months,
  • Significant cognitive impairment, terminal illness, severe psychiatric condition (e.g., bipolar disorder or schizophrenia disorder), or epilepsy.
  • Currently pregnant.
  • Previous sleepiness-related motor-vehicle accident.
  • Driver, pilot, or operates heavy machinery for work.
  • No self-reported risk of self-harm (identified by a score of greater than or equal to 1 on the PHQ-9, item 9).

结局指标

主要结局

Insomnia Severity Index (ISI) questionnaire.<br><br>[Between-group change in self-reported insomnia severity on the Insomnia Severity Index (ISI) questionnaire. Between-group change in ISI scores from baseline to 10-weeks and 6-month follow-up post-randomisation.]

次要结局

  • Depressive symptoms.[Between-group change in self-reported depressive symptoms on the Patient Health Questionnaire (PHQ-9). Between-group change in PHQ-9 scores from baseline to 10-weeks and 6-month follow-up post-randomisation.];Use of medicines for insomnia (Assessed as a composite secondary outcome including prescription and over-the-counter medicines for insomnia).[Self-reported use of sedative-hypnotic, and over-the-counter medicines used for insomnia in the previous month. Assessed via self-report during online questionnaire batteries. Between-group difference in self-reported use of medicines for insomnia (binary outcome) at 10-weeks and 6-month follow-up post-randomisation.]

研究者

发起方
Department of Health and Aged Care - Medical Research Future Fund (MRFF)

相似试验

Research and Evaluation Study of digital Treatment... | 临床试验